公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer | SHANG-GIN WU ; JIN-YUAN SHIH | Molecular Cancer | 465 | 422 | |
2016 | The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients | SHANG-GIN WU ; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; CHIH-HSIN YANG ; Wen Y.-F.; JIN-YUAN SHIH | Oncotarget | 207 | 191 | |
2007 | MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib | Bean J.; Brennan C.; JIN-YUAN SHIH ; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU ; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; PAN-CHYR YANG ; Miller V.; Ladanyi M.; CHIH-HSIN YANG ; Pao W. | Proceedings of the National Academy of Sciences of the United States of America | 1511 | 1379 | |
2007 | Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory | KANG-YI SU ; Chien W.-L.; WEN-MEI FU ; Yu I.-S.; HSIANG-PO HUANG ; PEI-HSIN HUANG ; Lin S.-R.; JIN-YUAN SHIH ; Lin Y.-L.; Hsueh Y.-P.; PAN-CHYR YANG ; SHU-WHA LIN | Journal of Neuroscience | 76 | 74 | |
2019 | MicroRNA in lung cancer metastasis | SHANG-GIN WU ; Chang T.-H.; Liu Y.-N.; JIN-YUAN SHIH | Cancers | 53 | 47 | |
2018 | Miliary pulmonary nodules: An unusual presentation of leptospirosis | YUNG-HSUAN CHEN ; CHING-YAO YANG ; JIN-YUAN SHIH ; CHONG-JEN YU | American Journal of Respiratory and Critical Care Medicine | 1 | 1 | |
2020 | miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; TZU-HSIU TSAI ; Gow, Chien-Hung; Wang, Hsin-Yi; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | 25 | 26 | |
2020 | MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process | Wang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH | Cancer biomarkers : section A of Disease markers | 25 | 20 | |
2024 | miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 | SHANG-GIN WU ; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; YEN-LIN HUANG ; Hsu, Chia-Lang; Jheng, Han-Nian; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | | | |
2023 | MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis | TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH | Cancer medicine | 0 | 0 | |
2008 | Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPα | Wu C.-C.; Lin J.-C.; Yang S.-C.; Lin C.-W.; Chen J.J.W.; JIN-YUAN SHIH ; Hong T.-M.; PAN-CHYR YANG | Molecular Cancer Therapeutics | 16 | 16 | |
2021 | Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | CHIA-LIN HSU ; TZU-HSIU TSAI ; CHUN-KAI HUANG ; CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; SHENG-YUAN RUAN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung cancer (Amsterdam, Netherlands) | 5 | 5 | |
2022 | Multi-energy level fusion for nodal metastasis classification of primary lung tumor on dual energy CT using deep learning | Wang, You-Wei; Chen, Chii-Jen; Wang, Teh-Chen; Huang, Hsu-Cheng; HSIN-MING CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; YU-SEN HUANG ; YEUN-CHUNG CHANG ; RUEY-FENG CHANG | Computers in Biology and Medicine | 7 | 4 | |
2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
2021 | Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 | KUEI-PIN CHUNG ; YEN-LIN HUANG ; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang ; Nakahira, Kiichi; Huang, Yen-Tsung; MONG-WEI LIN ; SHANG-GIN WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | Molecular Oncology | 10 | 8 | |
2014 | Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case | Gow C.-H.; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH | Medical Oncology | 24 | 21 | |
2017 | Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors | Wang H.-Y.; CHAO-CHI HO ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 9 | 7 | |
2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
2002 | New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | American Journal of Surgical Pathology | 104 | 84 | |
2019 | Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors | LIH-CHYUN CHANG ; Lim, Chor-Kuan; LIH-YU CHANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | European Journal of Cancer | 21 | 19 | |